JUNO THERAPEUTICS, INC. is a South Dakota corporation, registered on November 21, 2022. It is based at 400 Dexter Avenue North, Suite 1200, Seattle, WA, 98109. The company is currently listed as active on the South Dakota register, is registered under company number FB239057 and carries EIN 463656275. Public records for the company include 1 SoS registration, 12 licenses, 60 H-1B filings and 6 Form 5500 filings. Every fact here is republished from an official public register and traces back to a primary source document.
| Legal entity name | JUNO THERAPEUTICS, INC. |
|---|---|
| Principal address | 400 Dexter Avenue North, Suite 1200Seattle98109WAUnited States |
| Registration state | South Dakota |
| Status | Active |
| Formed in | Delaware (foreign registration) |
| Home company | JUNO THERAPEUTICS, INC. |
| Registered | 21 November 2022 (almost 4 years ago) |
| Entity type | Corporation |
| Standing | compliant |
| Company number | FB239057 |
| EIN | 463656275 |
| LEI | 5493004CAOW3ZGG2CV25 |
| Employees (modeled) |
| β834 employees2018 |
| H-1B filings | 60 LCA filings, FY 2015β2022 |
|---|
| Registered agent | C T CORPORATION SYSTEM |
|---|
| Source registry | South Dakota Secretary of State Β· updated 15 June 2026 |
|---|
| Public records | 1 SoS registration |
|---|
Direct email, phone, website, address and the contact person are unlocked with a Pro subscription. Create an account to reveal them.
| Est. revenue (modeled) | $299M2018 |
|---|
| State | Business name | Filed | Registered agent | Officers | Status | |
|---|---|---|---|---|---|---|
| South DakotaTHIS | JUNO THERAPEUTICS, INC. | 2022-11-21 | C T CORPORATION SYSTEM | β | Active | |
Filing ID FB239057 Jurisdiction Foreign Β· CorporationFormed in Delaware Principal address 400 Dexter Avenue North, Suite 1200, Seattle, WA, 98109 Registered agent C T CORPORATION SYSTEM319 S COTEAU ST, PIERRE, SD, 57501-3187 Officers Not reported | ||||||
| Alaska | Juno Therapeutics, Inc. | 2021-02-18 | C T Corporation System | Amy FalloneSecretary, DirectorSandra Ramos-AlvesTreasurer, Director4 more | Active | |
| Alabama | Juno Therapeutics, Inc. | 2017-12-28 | C T CORPORATION SYSTEM | β | Active | |
| California | JUNO THERAPEUTICS, INC. | 2017-04-03 | C T CORPORATION SYSTEM | Sophia ParkOfficerAmy FalloneOfficer3 more | Active | |
| Colorado | Juno Therapeutics, Inc. | 2018-03-12 | C T CORPORATION SYSTEM | β | Active | |
| Connecticut | JUNO THERAPEUTICS, INC | 2017-01-04 | C T CORPORATION SYSTEM | Elisabeth S. BradleyOfficerScott MatareseOfficer5 more | Active | |
| Delaware | JUNO THERAPEUTICS, INC. | 2013-08-05 | THE CORPORATION TRUST COMPANY | β | Unknown | |
| Florida | JUNO THERAPEUTICS, INC. | 2017-05-25 | C T CORPORATION SYSTEM | SOPHIA PARKOfficer, DirectorKimberly M JablonskiOfficer, Director7 more | Active | |
| Illinois | JUNO THERAPEUTICS, INC. | 2017-01-12 | C T CORPORATION SYSTEM | β | Active | |
| Kentucky | JUNO THERAPEUTICS, INC. | 2021-06-02 | CT CORPORATION SYSTEM | Sandra Ramos-AlvesOfficer, DirectorScott MatareseOfficer4 more | Active | |
| Massachusetts | JUNO THERAPEUTICS, INC. | 2015-06-08 | C T CORPORATION SYSTEM | Amy FalloneOfficer, DirectorTaylor OcasioOfficer4 more | Active | |
| Maine | JUNO THERAPEUTICS, INC. | 2021-03-18 | C T CORPORATION SYSTEM | β | Active | |
| Montana | Juno Therapeutics, Inc. | 2021-02-18 | C T CORPORATION SYSTEM | Sandra Ramos-AlvesOfficer, DirectorSophia ParkOfficer, Director4 more | Active | |
| North Dakota | Juno Therapeutics, Inc. | 2021-03-15 | C T CORPORATION SYSTEM | β | Active | |
| New Hampshire | JUNO THERAPEUTICS, INC. | 2017-01-06 | C T Corporation System | Sandra Ramos-AlvesDirector, OfficerSophia ParkDirector, Officer4 more | Active | |
| Nevada | Juno Therapeutics, Inc. | 2021-02-18 | C T CORPORATION SYSTEM** | Amy FalloneDirector, OfficerSophia ParkDirector, Officer1 more | Active | |
| Oklahoma | JUNO THERAPEUTICS, INC. | 2018-02-23 | C T CORPORATION SYSTEM | β | Active | |
| Oregon | JUNO THERAPEUTICS, INC. | 2015-11-17 | C T CORPORATION SYSTEM | SOPHIA PARKOfficerAMY FALLONEOfficer | Active | |
| Pennsylvania | Juno Therapeutics, Inc. | 2015-06-25 | β | Amy FalloneOfficer, DirectorElisabeth S. BradleyOfficer4 more | Active | |
| Rhode Island | Juno Therapeutics, Inc. | 2018-01-02 | CT CORPORATION SYSTEM | AMY FALLONEDirectorTAYLOR OCASIOOfficer4 more | Active | |
| South Carolina | JUNO THERAPEUTICS, INC. | 2015-09-08 | CORPORATION SERVICE COMPANY | β | Inactive | |
| Texas | Juno Therapeutics, Inc. | 2017-05-03 | C T Corporation System | Kimberly McCutcheon JablonskiOfficerElisabeth S BradleyOfficer4 more | Active | |
| Utah | JUNO THERAPEUTICS, INC | 2017-01-20 | CORPORATION SERVICE COMPANY | KIMBERLY M. JABLONSKIOfficer, DirectorElisabeth S. BradleyOfficer6 more | Active | |
| Virginia | Juno Therapeutics, Inc. | 2016-12-30 | C T CORPORATION SYSTEM | Sandra Ramos-AlvesOfficerElisabeth S. BradleyOfficer5 more | Active | |
| Vermont | JUNO THERAPEUTICS, INC. | 2021-03-30 | C T CORPORATION SYSTEM | Amy FalloneOfficer, DirectorSandra Ramos-AlvesOfficer, Director4 more | Active | |
| Washington | JUNO THERAPEUTICS, INC. | 2013-10-14 | C T CORPORATION SYSTEM | SCOTT MATARESEDirectorAMY FALLONEDirector4 more | Active | |
Companies and people linked to JUNO THERAPEUTICS, INC. in the state registers through shared officers, a shared registered agent, shared filing contacts or a shared address. Service companies file for many unrelated businesses β a shared agent, address or contact alone does not prove affiliation.
company person group former role
Browse the indexed registries by state, or look up any debtor name free, at UCC lien search.
| State | License / ID | Type | Issued | Status | |
|---|---|---|---|---|---|
| Illinois | 004005027 | PHARMACY | 2024-12-18 | ACTIVE | |
| Connecticut | β | β | 2022-05-24 | ACTIVE | |
| New Hampshire | 07201 | MAN/DIST/WHOLE/BROKER | 2021-06-14 | Active - Renewal | |
| Connecticut | β | β | 2021-02-11 | ACTIVE | |
| Connecticut | β | β | 2020-06-19 | ACTIVE | |
| Connecticut | β | BUSINESS | β | ACTIVE | |
| Connecticut | β | CORPORATION | β | ACTIVE | |
| Connecticut | β | CORPORATION | β | ACTIVE | |
| β | β | β | β | Unknown | |
| β | β | β | β | Unknown | |
| Case | Filed | Job title | Wage | Worksite | Status | |
|---|---|---|---|---|---|---|
| I-200-22220-401982 | 2022-08-08 | Associate Scientist | $103,960/yr | Seattle | Certified | |
| I-200-21260-592372 | 2021-09-17 | Manager, IT Quality & Compliance | $100,000/yr | Bothell | Certified | |
| I-200-21235-537976 | 2021-08-23 | Manufacturing Execution Systems Analyst | $110,000/yr | Bothell | Certified | |
| I-200-21215-499117 | 2021-08-03 | Cell Therapy Media Specialist, Manufacturing | $118,000/yr | Bothell | Certified | |
| I-200-21210-489826 | 2021-07-28 | Manager, Computer System Validation | $115,000/yr | Bothell | Certified | |
| I-200-20240-791774 | 2020-08-27 | Process Engineer | $63,978/yr | Seattle | Certified | |
| I-200-20226-767362 | 2020-08-13 | Principal Scientist, Cell Therapy Predictive Sciences | $177,866/yr | Los Angeles | Certified | |
| I-200-20224-763421 | 2020-08-11 | Senior Manufacturing Systems Engineer | $137,917/yr | Bothell | Certified | |
| I-200-20220-758298 | 2020-08-07 | Principal Scientist, Cell Therapy Predictive Sciences | $177,866/yr | Los Angeles | Withdrawn | |
| I-200-19197-685753 | 2019-07-22 | PROJECT MANAGER | $115,000/yr | Seattle | CERTIFIED | |
Employee-benefit plan filings by JUNO THERAPEUTICS, INC. with the Department of Labor. Employee and revenue figures are modeled estimates derived from retirement-plan participant counts and industry ratios β not official headcount or reported revenue.
| Employees (modeled) | β834 Β· plan year 2018 |
|---|---|
| Est. annual revenue (modeled) | $299M |
| Benefit plans | 401(k) plan on file Β· plan terminated |
| Filing history | 5 plan years filed, 2014β2018 |
| Sponsor EIN | 46-3656275 |
| Plan year | Employees (est.) | Participants | Plan assets | Revenue (est.) | 401(k) | |
|---|---|---|---|---|---|---|
| 2018 | β834 | 751 | β | $299M | 401(k) | |
| 2017 | β694 | 531 (625 active) | $17.5M | $213.8M | 401(k) | |
| 2016 | β570 | 280 (513 active) | $9.6M | $154.3M | 401(k) | |
| 2015 | β106 | 97 (95 active) | $3.6M | $42.8M | 401(k) | |
| 2014 | β13 | 12 (12 active) | $734,352 | $7.4M | 401(k) | |
Matched Form 5500 filing records:
| Plan | Plan year | Participants | EIN | |
|---|---|---|---|---|
| JUNO THERAPEUTICS, INC. 401(K) PLAN AND TRUST | β | β | β | |
| JUNO THERAPEUTICS, INC. 401(K) PLAN AND TRUST | β | β | β | |
| JUNO THERAPEUTICS, INC. 401(K) PLAN AND TRUST | β | β | β | |
| JUNO THERAPEUTICS, INC. 401(K) PLAN AND TRUST | β | β | β | |
| JUNO THERAPEUTICS, INC. 401(K) PLAN AND TRUST | β | β | β | |
| JUNO THERAPEUTICS, INC. 401(K) PLAN AND TRUST | β | β | β | |
Federal court records load when you reach this section.
13 companies are registered at 400 Dexter Avenue North, Suite 1200, Seattle β shared registered-office and agent addresses are common; a shared address alone does not link businesses.
Netstate aggregates public records from federal, state and municipal sources; records are matched to this company by its registered legal names. Latest source snapshot 2026-07-29. Document getpalm-companies/2608-3838-1371.